Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

FDA clears Gynesonics’ sonography-guided transcervical fibroid ablation system

August 22, 2018 By Nancy Crotti

Sonata system in use. (Image courtesy of Gynesonics.)

Women’s healthcare company Gynesonics (Redwood City, Calif.) said it has received 510(k) clearance from the FDA to market its Sonata sonography-guided transcervical fibroid ablation system.

Sonata combines a breakthrough integrated technology — the first intrauterine ultrasound system — with a proprietary radiofrequency ablation device, providing a transcervical, incision-free, uterus-preserving treatment for uterine fibroids, the company said in a statement.

With an estimated volume of more than 1 million annual global fibroid procedures, Gynesonics projects a $3 billion-$4 billion global market opportunity for Sonata, including a market opportunity of more than $1 billion in the U.S. alone.

“We are excited to announce FDA clearance of our Sonata system. This is an essential milestone for Gynesonics in our mission to bring this transformational technology for the treatment of uterine fibroids to women,” Gynesonics president & CEO Christopher Owens said in the statement. “The patient outcomes achieved with Sonata demonstrate its potential to become a new standard of care in fibroid treatment, providing important patient benefits as compared to invasive surgery. Clinical trial outcomes show that Sonata provides a significant and durable improvement in symptoms with more than half the women returning to normal activities within 24 hours.”

Although they may not cause symptoms in many cases, fibroids can lead to heavy menstrual bleeding, infertility, miscarriage and early onset of labor. Hysterectomy is an effective treatment, but many uterine-sparing options are available, according to the National Institutes of Health (NIH).  Current transcervical options are limited to treatment of a small portion of the total fibroid market by comparison, according to Owens.

Most U.S. women will develop fibroids at some point in their lives, according to the  NIH. Eighty percent of African American women and 70% of white women had fibroids by age 50, the NIH said, citing a 2003 American Journal of Obstetrics and Gynecology article.

A survey of 968 women affected by fibroids, published in the same journal in 2013, found that 79% want to avoid invasive surgery, most wait an average of 3.6 years before seeking treatment, and most also want to preserve their uterus.

Gynesonics exceeded the FDA-specified 12-month primary endpoint performance requirements for the Sonata system used to support the FDA regulatory 510(k) filing, the company said. The co-primary endpoints in the pivotal IDE clinical trial included a significant reduction in bleeding and a high rate of freedom from surgical reintervention due to heavy menstrual bleeding. The safety outcomes included zero device-related adverse events reported in the 147-patient trial, the company noted.

The Sonata system also holds the CE Mark.

Related Articles Read More >

A portrait of Zimmer Biomet CEO Bryan Hanson
Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
A portrait of Britt Meelby Jensen, the new CEO of Ambu
Ambu replaces CEO with new leadership
AdvaMed
AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
A photo of former FDA official Bakul Patel
Google Health hires FDA’s chief digital health officer

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech